SPRB
Spruce Biosciences, Inc. Common Stock
SPRB
SPRB
About: Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT), and Tildacerfont/ Cortibon, a Companion Diagnostic, developed in partnership with HMNC Brain Health.
Employees: 20
–
Funds
holding %
–
Analysts
bullish %
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
90% less funds holding
Funds holding: 30 [Q1] → 3 (-27) [Q2]
95% less capital invested
Capital invested by funds: $3.02M [Q1] → $147K (-$2.88M) [Q2]
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 27
Financial journalist opinion
Charts implemented using
Lightweight Charts™